Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP923890.RAOxP1XNiAMh2l5IXCUoTDh8CM0-MP3-uE5ifWLEo0-Yg130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP923890.RAOxP1XNiAMh2l5IXCUoTDh8CM0-MP3-uE5ifWLEo0-Yg130_assertion type Assertion NP923890.RAOxP1XNiAMh2l5IXCUoTDh8CM0-MP3-uE5ifWLEo0-Yg130_head.
- NP923890.RAOxP1XNiAMh2l5IXCUoTDh8CM0-MP3-uE5ifWLEo0-Yg130_assertion description "[Our study demonstrates that (i) ErbB/HER ligands, including BTC and EREG, are expressed in most breast cancers; and (ii) TGFalpha, HB-EGF and NRG2 high expressions are related to the biological aggressiveness of the tumours.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP923890.RAOxP1XNiAMh2l5IXCUoTDh8CM0-MP3-uE5ifWLEo0-Yg130_provenance.
- NP923890.RAOxP1XNiAMh2l5IXCUoTDh8CM0-MP3-uE5ifWLEo0-Yg130_assertion evidence source_evidence_literature NP923890.RAOxP1XNiAMh2l5IXCUoTDh8CM0-MP3-uE5ifWLEo0-Yg130_provenance.
- NP923890.RAOxP1XNiAMh2l5IXCUoTDh8CM0-MP3-uE5ifWLEo0-Yg130_assertion SIO_000772 17962208 NP923890.RAOxP1XNiAMh2l5IXCUoTDh8CM0-MP3-uE5ifWLEo0-Yg130_provenance.
- NP923890.RAOxP1XNiAMh2l5IXCUoTDh8CM0-MP3-uE5ifWLEo0-Yg130_assertion wasDerivedFrom befree-20140225 NP923890.RAOxP1XNiAMh2l5IXCUoTDh8CM0-MP3-uE5ifWLEo0-Yg130_provenance.
- NP923890.RAOxP1XNiAMh2l5IXCUoTDh8CM0-MP3-uE5ifWLEo0-Yg130_assertion wasGeneratedBy ECO_0000203 NP923890.RAOxP1XNiAMh2l5IXCUoTDh8CM0-MP3-uE5ifWLEo0-Yg130_provenance.